Q1 2021 Holdings
Filed 2021-05-17 | 31 holdings | $62.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-10-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $25.9M | 1,028,084 | 41.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $17.8M | 481,094 | 28.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.1M | 1,269,195 | 17.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $7.6M | 369,951 | 12.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $14.7K | 521,555 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $14.4K | 2,431,705 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $13.6K | 361,344 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $13.5K | 2,983,513 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $10.7K | 1,729,041 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.1K | 349,600 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $8.7K | 298,839 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $8.6K | 368,448 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $8.5K | 795,868 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $7.9K | 3,729,694 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $7.8K | 2,871,624 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.9K | 429,228 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $6.9K | 2,048,757 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.7K | 430,112 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.7K | 161,565 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.5K | 214,467 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.4K | 301,392 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.3K | 236,500 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $5.1K | 176,821 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $4.2K | 97,143 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.1K | 125,000 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.9K | 262,658 | 0.0% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $3.1K | 185,781 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $2.9K | 141,303 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.6K | 250,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.5K | 46,630 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $1.0K | 100,000 | 0.0% |